Healthy volunteers test two injection devices for drug delivery

NCT ID NCT06475729

Completed Knowledge-focused Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well two different autoinjectors deliver the drug mirikizumab into the bloodstream of healthy people. About 500 healthy adults received a single injection under the skin using either a standard 1-mL autoinjector or a newer 2-mL version. The goal was to see if the two devices work the same way, not to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Locations

CenExel ACT

Anaheim, California, 92801, United States
Clinical Pharmacology of Miami

Miami, Florida, 33014-3616, United States
Fortrea Clinical Research Unit

Daytona Beach, Florida, 32117, United States
Fortrea Clinical Research Unit

Dallas, Texas, 75247, United States
Fortrea Clinical Research Unit

Madison, Wisconsin, 53704, United States
QPS Missouri

Springfield, Missouri, 65802, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.